
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577) has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada.
PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative.
Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency.
LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions.
"We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan."This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field."
About Innocan:
Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales.
Contact Information:
For Innocan Pharma Corporation:
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
[email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution Regarding Forward-Looking Information
Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at www.sedarplus.ca.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
3 hours ago
- Cision Canada
Media Advisory - Simultaneous launch of Canadian space technologies Français
LONGUEUIL, QC, June 21, 2025 /CNW/ - Several technologies funded by the Canadian Space Agency under the Space Technology Development Program will be launched into space by SpaceX. These projects are a testament to Canada's leadership in space innovation. EarthDaily Analytics will use high-precision thermal imagers to monitor plant transpiration. The data collected could help farmers make decisions about irrigation, fertilization and crop rotation. It could also provide precise information about areas at greatest risk of wildfires, in order to protect our communities. INO provided infrared cameras as part of this project. Galaxia will launch its first satellite, MÖBIUS-1, a software-defined satellite designed to carry various types of Earth observation sensors. The MÖBIUS constellation could be used for a variety of applications, such as defence, environmental monitoring, agriculture, infrastructure, maritime operations and transportation. GHGSat will add two satellites to its commercial constellation, bringing the company's total to 13 methane detection satellites and one CO 2 detection satellite. Mission Control will test its onboard artificial intelligence (AI) software and machine learning operations system SpacefarerAI™ in partnership with Spire Global. Their Persistence mission aims to show how AI can analyze satellite images directly in space, thereby eliminating the need to send all data to Earth for processing. Xona Space Systems will test Pulsar, a demonstration satellite designed to validate a new generation of satellite navigation from low Earth orbit. This technology could improve precision and reliability of positioning services, including in urban areas, remote areas and the Arctic. Also contributing to the GHGSat and EarthDaily Analytics satellites are ABB 's business unit in Quebec, supplying sophisticated optical sensors, and Xiphos Systems, providing high-performance onboard processors. These innovations demonstrate the ability of Canadian companies to develop innovative technologies that meet the needs of the space program and have strong commercial potential. Media who wish to speak with a Canadian Space Agency expert or a representative from one of these Canadian companies are asked to contact the Media Relations Office.


Cision Canada
3 hours ago
- Cision Canada
Statement by Prime Minister Carney on National Indigenous Peoples Day Français
OTTAWA, ON, /CNW/ - "In my first months as Prime Minister, I have been grateful for the opportunity to meet with First Nations, Inuit, and Métis, and I recognize there is much more work to do together. "The government will work in full partnership with Indigenous Peoples – advancing shared priorities such as health care, food security, housing, education, economic prosperity, conservation, climate action, and emergency management to build a better future. Indigenous partnership is a critical component of the One Canadian Economy Act, and shared leadership with First Nations, Inuit, and Métis will be pivotal to the success of building major projects in Canada. "We will move forward together on the Truth and Reconciliation Commission's Calls to Action, the National Inquiry into Missing and Murdered Indigenous Women and Girls' Calls for Justice, and the implementation of the United Nations Declaration on the Rights of Indigenous Peoples Act. "Supporting Indigenous communities, advancing self-determination, implementing treaties, and creating generational wealth and prosperity are central to our commitment to advancing reconciliation. Through initiatives like the Indigenous Loan Guarantee Program, we're addressing the historical, systemic, and economic barriers that have prevented Indigenous Peoples from participating in – and benefitting from – economic opportunities, particularly in the natural resource sector. "Today, on National Indigenous Peoples Day, and every day, we honour the enduring histories, cultures, and contributions of First Nations, Inuit, and Métis, and we reaffirm our partnership in reconciliation. Together, we can build a better future, a stronger economy, and a legacy that future generations can inherit and carry forward."


Cision Canada
5 hours ago
- Cision Canada
Statement by Minister Valdez to mark National Indigenous Peoples Day Français
OTTAWA, ON, /CNW/ - The Honourable Rechie Valdez, Minister of Women and Gender Equality and Secretary of State (Small Business and Tourism), made the following statement: "Today, I join communities across the country in celebrating National Indigenous Peoples Day. "This is a time to honour the rich histories, vibrant cultures and enduring contributions of First Nations, Inuit, and Métis. From coast to coast to coast, we celebrate the strength, resilience, and leadership of Indigenous communities. "Today, more than 50,000 small businesses are majority-owned by Indigenous entrepreneurs. Indigenous-led businesses are fuelling economic growth and uplifting communities across the country. "In 2023 alone, Indigenous tourism operators generated an estimated 34,700 jobs and billions of dollars in economic activity. These numbers tell a powerful story of resilience and innovation and highlight the vital role Indigenous businesses play in our tourism economy. "As Minister of Women and Gender Equality, I am committed to supporting Indigenous-led efforts to end gender-based violence. Through the National Action Plan to End Gender-Based Violence and the Federal Pathway to Address Missing and Murdered Indigenous Women, Girls and 2SLGBTQQIA+ Peoples, our government is working in partnership with First Nations, Inuit and Métis communities to develop policies and fund programs to end the national crisis facing Indigenous women, girls and 2SLGBTQQIA+ people. This work is essential to healing, justice and safety for Indigenous women, girls and 2SLGBTQQIA+ people, wherever they live. "Our government is deeply committed to advancing reconciliation and to building lasting partnerships with Indigenous Peoples by supporting entrepreneurs, fostering economic opportunity and building an inclusive economy that leaves no one behind. Stay connected Follow the department on . For easy access to government programs for businesses, download the Canada Business app.